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Abstract
Background: One of the potentially important applications of three-dimensional (3D) intracranial vessel wall (IVW)
cardiovascular magnetic resonance (CMR) is to monitor disease progression and regression via quantitative measurement
of IVW morphology during medical management or drug development. However, a prerequisite for this application is to
validate that IVW morphologic measurements based on the modality are reliable. In this study we performed
comprehensive reliability analysis for the recently proposed whole-brain IVW CMR technique.
Methods: Thirty-four healthy subjects and 10 patients with known intracranial atherosclerotic disease underwent
repeat whole-brain IVW CMR scans. In 19 of the 34 subjects, two-dimensional (2D) turbo spin-echo (TSE) scan was
performed to serve as a reference for the assessment of vessel dimensions. Lumen and wall volume, normalized wall
index, mean and maximum wall thickness were measured in both 3D and 2D IVW CMR images. Scan-rescan, intra-
observer, and inter-observer reproducibility of 3D IVW CMR in the quantification of IVW or plaque dimensions were
respectively assessed in volunteers and patients as well as for different healthy subjectsub-groups (i.e. < 50 and≥
50 years). The agreement in vessel wall and lumen measurements between the 3D technique and the 2D TSE method
was also investigated. In addition, the sample size required for future longitudinal clinical studies was calculated.
Results: The intra-class correlation coefficient (ICC) and Bland-Altman plots indicated excellent reproducibility and
inter-method agreement for all morphologic measurements (All ICCs > 0.75). In addition, all ICCs of patients were equal
to or higher than that of healthy subjects except maximum wall thickness. In volunteers, all ICCs of the age group of
≥50 years were equal to or higher than that of the age group of < 50 years. Normalized wall index and mean and
maximum wall thickness were significantly larger in the age group of ≥50 years. To detect 5% - 20% difference
between placebo and treatment groups, normalized wall index requires the smallest sample size while lumen volume
requires the highest sample size.
Conclusions: Whole-brain 3D IVW CMR is a reliable imaging method for the quantification of intracranial vessel
dimensions and could potentially be useful for monitoring plaque progression and regression.
Keywords: Intracranial vessel wall morphology, Vessel wall imaging, Whole-brain, Reliability, Magnetic resonance
imaging, Intracranial atherosclerotic disease
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Background
Intracranial atherosclerotic disease (ICAD) is one of the
major causes for cerebrovascular events such as stroke and
transient ischemic attack [1, 2]. Luminography imaging, rou-
tinely used in the diagnostic workup of ICAD, is restricted
to the detection of luminal stenosis, which is, however, not a
specific marker for confirming and risk-stratifying athero-
sclerotic plaques [3]. In contrast, high-resolution black-
blood cardiovascular magnetic resonance (CMR) can dir-
ectly visualize the intracranial vessel wall (IVW) and has
demonstrated the potential to characterize plaque features
that are intimately associated with clinical events [4–8].
Three-dimensional (3D) turbo spin-echo (TSE) with
variable refocusing flip angles, as a black-blood CMR tech-
nique, has recently gained growing interest among the
IVW imaging research community [9–15]. Compared
with a conventionally used two-dimensional (2D) TSE
method, the 3D approach provides larger spatial coverage,
higher spatial resolution and signal-to-noise ratio (SNR),
and the flexibility in image visualization, which are all de-
sirable for visualizing small, tortuous, and deep-seated
intracranial arteries. Continued technical improvements
are being introduced to the technique, primarily in signal
suppression of the cerebrospinal fluid (CSF) [16–19] and
arterial blood [17], spatial coverage [16, 18], and scan effi-
ciency [20]. Notably, a whole-brain IVW CMR imaging
method was recently developed by incorporating non-
selective excitation and a trailing magnetization flip-down
module with a commercially available 3D TSE sequence -
Sampling Perfection with Application-optimized Contrast
using different flip angle Evolutions (SPACE) [18]. Re-
markable CSF signal attenuation and enhanced image
SNR and T1 contrast weighting make the technique well
suited for evaluating vessel wall morphology and revealing
plaque features with a characteristic hyper-intense appear-
ance such as intra-plaque hemorrhage and post-contrast
wall enhancement. With additional optimization at 3
Tesla, a 3D scan with a whole-brain spatial coverage and
isotropic 0.5-mm spatial resolution can be completed
within 7–8 min [20]. Such improved imaging efficiency
further strengthens its applicability for clinical settings.
One of the potentially important applications of 3D IVW
CMR is to monitor ICAD progression and regression via
quantitative measurement of vessel wall morphology during
medical management or drug development. Demonstrated
in extracranial vascular beds, several plaque morphologic
measures derived by high-resolution black-blood CMR,
such as mean wall thickness, plaque burden, and wall re-
modeling ratio, may serve as imaging surrogates for thera-
peutic responses [21–24]. A key prerequisite for 3D IVW
CMR to become an imaging tool for longitudinal ICAD as-
sessment is the reliability of the technique in vessel wall
and lumen dimension quantification. However, there is a
paucity of data reported on the aspect [9, 25].
The purpose of this study was to perform comprehen-
sive reliability analysis for 3D IVW CMR, particularly the
recently proposed whole-brain IVW CMR imaging tech-
nique [20]. Scan-rescan, intra-observer, and inter-observer
reproducibility in the quantification of intracranial vessel
dimensions were respectively assessed for healthy subjects
and patients with ICAD as well as for different sub-groups
(i.e. age < 50 and ≥ 50 years). The agreement in vessel wall
and lumen measurements between the 3D technique and
the conventionally used 2D TSE method was also investi-
gated in a subgroup of the subjects. In addition, the sam-
ple size required for future longitudinal clinical studies
was calculated. The findings from this study are expected
to indicate the performance of the method in general pop-
ulations and to provide insights into planning future stud-
ies on clinical patients.
Methods
Study population
The prospective study was approved by the local institu-
tional review board. Thirty-four healthy subjects (24
males; 14 aged 31–49 years and 20 aged 50–66 years)
without known cerebrovascular diseases and 10 patients
(7 males; 42–69 years, mean 51.2 years) with known
ICAD were recruited. Written informed consent was ob-
tained from all subjects.
Imaging protocol
All CMR examinations were performed on a 3-Tesla
whole-body system (MAGNETOM Verio, Siemens
Healthineers, Erlangen, Germany) with a 32-channel
head coil. Subjects were scanned in a supine position
with a foam padding to minimize head movement. Two
repeated 3D IVW CMR scans were performed with an
off-table break for healthy subjects and 7 to 11-day in-
tervals for patients [18, 20]. When any of the two scans
exhibited motion-related image blurring at the discretion
of the CMR technologist, reacquisition was attempted
only once to simulate real clinical settings. Relevant im-
aging parameters were as follows: sagittal imaging orien-
tation, repetition time (TR) /echo time (TE) = 900/
15 ms, receiver bandwidth = 488 Hz/pixel, field of view
= 170 × 170 × (110–127) mm3, matrix size = 320 ×
320 × (208–240) with 7.7–6.7% partition oversampling,
spatial resolution = 0.53 × 0.53 × 0.53 mm3 (without
zero-filled interpolation), turbo factor = 52, echo train
duration = 271 ms, 6/8 partial Fourier in the partition-
encoding direction, parallel imaging (GRAPPA) acceler-
ation rate = 2 in the phase-encoding direction, scan time
= 7 min 10 s – 8 min 10 s depending on the head size.
In 19 out of the 34 healthy subjects, T1-weighted 2D
TSE was also performed during the rescan session to
provide an CMR imaging reference for assessing the
inter-method agreement. Due to its relatively poor scan
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efficiency, the acquisition was prescribed only for three ar-
terial segments that often present with ICAD in patients,
including the distal basilar artery (BA), distal internal ca-
rotid artery (ICA) supraclinoid segment (C4), and prox-
imal middle cerebral artery (MCA) M1 segment.
Immediately after the 3D IVW CMR rescan, 3D images
were reconstructed into three contiguous 2-mm-thick
cross-sections at each of the three segments by an experi-
enced CMR technologist using the multiplanar recon-
struction (MPR) functionality available on the imaging
console. A 2D TSE image was then acquired for each of
these cross-sections with following imaging parameters:
TR/TE = 800/12 ms, receiver bandwidth = 411 Hz/pixel,
field of view = 170 × 170 mm3, matrix size = 320 × 320,
spatial resolution = 0.53 × 0.53 mm2, slice thickness =
2 mm, turbo factor = 9, signal averages = 4, scan time per
slice = 1 min 37 s.
Image analysis
All images were transferred to a workstation (Syngo
MultiModality Workplace, Siemens Healthineers). The
scan and rescan 3D IVW CMR image sets were first co-
registered using an image fusion functionality to account
for head repositioning. At the same locations on both
image sets, 5 following vessel segments were analyzed
for each healthy subject: the distal BA, the distal verte-
bral artery (VA; V4), the distal ICA C4, the proximal
MCA M1, and the proximal anterior cerebral artery
(ACA) A1. Three contiguous cross-sections of 2-mm
thickness were generated via MPR for each segment. For
each patient, 3 contiguous cross-sections of 2-mm thick-
ness centered at the thickest location of the most sten-
otic plaque were also generated via MPR.
All these reconstructed cross-sectional images and
corresponding 2D TSE images underwent vessel wall
and lumen dimension quantification using commercial
software (VesselMass, Leiden University Medical Center,
Leiden, the Netherlands). Each image was magnified 4–6
times with bilinear interpolation. Lumen and outer wall
boundaries were traced manually along the interfaces
between the lumen and wall and between the wall and
surrounding tissue respectively, generating two contours
(Fig. 1). When part of a boundary was invisible, the con-
tour was completed to maintain the continuity of the
vessel’s curvature [9]. The entire vessel wall region
encased by the two contours were automatically divided
into ten evenly spaced segments. The software generated
the following measurements: the average and maximum
wall thickness (i.e. the mean and maximum value of the
ten distances between contours), the lumen area (i.e. the
area inside the luminal contour), and the wall area (i.e.
subtracting the inner contour area from the outer con-
tour area). Additionally, normalized wall index was cal-
culated as the ratio of the wall area to the outer contour
area. Contouring and determination of the above wall
and lumen dimensions for any 3 consecutive slices re-
quired a processing time of approximately 2.5 min per
scan. For each vessel segment or plaque, the measured
normalized wall index and mean/maximum wall thick-
ness were, respectively, averaged over the three slices;
lumen volume and wall volume were obtained by sum-
ming the area measurements of the three slices and
multiplying by 2 mm.
Two readers (with 6-year and more than 10-year ex-
perience in vascular CMR imaging, respectively) inde-
pendently performed above vessel wall and lumen
measurements on the images from the first 3D IVW
CMR scan. After two weeks, one of the readers per-
formed a second-round measurement on the same data,
and the other performed measurement on the images
from the second scan followed by measurement another
2 weeks later for the 2D TSE scan when available.
Statistical analysis
All statistical analyses were performed using SPSS (ver-
sion 19.0, International Business Machines, Armonk,
New York, USA) and R (version 3.4.1). Intra-class cor-
relation coefficient (ICC) was obtained from a two-way
random model with two raters for inter-rater reproduci-
bility and a two-way mixed model with two raters for
intra-rater and scan-rescan reproducibility. Confidence
intervals for the overall ICC were calculated by boot-
strap taking in account the correlation between seg-
ments in the same patient. An ICC value of less than 0.4
was considered poor agreement, a value of 0.4–0.75 was
considered good agreement, and a value of 0.75 or
greater was considered excellent agreement [26]. Bland-
Altman analysis was also used to determine the scan-
rescan, intra-, and inter-observer reproducibility of 3D
IVW CMR as well as inter-method agreement between
3D IVW CMR and 2D TSE in quantifying vessel dimen-
sions for volunteers.
In addition, the healthy cohort was further categorized
by age into two groups, i.e. < 50 years and ≥50 years. All
above reproducibility were determined for each group.
Morphologic measurements averaged over the two
readers were used to determine the differences between
the two groups based on independent t-test. A two-
tailed P value of 0.05 or less was considered to indicate a
significant difference.
Based on the scan-rescan data analysis, the sample size
required for each of dimension measurements to com-
pare placebo and treatment group in a clinical trial with
80% of power at 5% significance level was calculated
using a t-test with equal variances. It was assumed that
the mean of the placebo group would be equal to the
mean from the healthy subjects in our study and that
the mean of the treatment group would be 5, 10, 15, and
Zhang et al. Journal of Cardiovascular Magnetic Resonance  (2018) 20:39 Page 3 of 12
20% different. The standard deviations for placebo and
treatment groups were assumed to be equal and given by
the subject variance estimated from a linear mixed model
with subject as fixed effect and scan as random effect.
Results
Motion-related vessel wall blurring was observed by the
CMR technologist in either of the two 3D IVW CMR
scans in 6 healthy subjects and 2 patients. Reacquisitions
in these subjects were performed and yielded acceptable
image quality in all but 2 healthy subjects (51 and
49 years) and 1 patient (61 years) who were excluded
from image analysis. Hence, a total of 160 paired arterial
segments from 32 healthy subjects (13: age < 50 years
and 19: age ≥ 50 years) and 9 plaques (5 on MCA, 2 on
BA, and 2 on VA) were available for reproducibility ana-
lysis; a total of 54 paired arterial segments from 18
healthy subjects were available for inter-method agree-
ment analysis.
Measurement reproducibility
3D IVW CMR provided visually consistent delineation
of the vessel wall (Fig. 2) and plaques (Fig. 3) in both
scans. In some plaques, high signal-intensity features
were observed (Fig. 3 case A). For healthy subjects, mor-
phologic measurements and corresponding ICC values,
when combining all assessed segments, are summarized
in Table 1 (Segment-based results are summarized in
Additional file 1: Table S1). Each of the assessed mor-
phologic indices had all ICCs greater than 0.75, indicat-
ing excellent reproducibility. More specifically, for the
intra-observer reproducibility, all ICCs were equal to or
greater than 0.93. For the scan-rescan and inter-observer
reproducibility, all ICCs except for that for the inter-
observer reproducibility on normalized wall index were
equal to or greater than 0.83. For patients, vessel wall
and lumen measurements at the most stenotic plaque
and corresponding ICC values are summarized in
Table 2. All ICCs except for that for the inter-observer
reproducibility on maximum wall thickness (ICC = 0.87)
were equal to or greater than 0.91, indicating excellent
reproducibility.
The Bland-Altman plots for all arterial segments of
healthy subjects are shown in Fig. 4 for lumen volume,
normalized wall index, and mean wall thickness, respect-
ively. Random error scattering patterns and independ-
ence of the difference on the mean value were observed.
All ICCs of the healthy subgroup age ≥ 50 years were
equal to or higher than that of the < 50 years sub-
groups, but in most cases, were lower than that of pa-
tients (Fig. 5). As shown in Table 3, there were no
significant difference in lumen or wall volume between
Fig. 1 Representative images of scan and rescan analysis of lumen and outer wall boundaries for the five designated arterial segments: the distal
basilar artery, the distal vertebral artery (VA (V4)), the distal internal carotid artery (ICA) supraclinoid segment (C4), the middle cerebral artery
(MCA) M1 segment, and anterior cerebral artery (ACA) A1 segments, from a 55-year-old male healthy subject
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Fig. 2 Representative 3D intracranial vessel wall MR images acquired in two scans from a 55-year-old male healthy subjects and reformatted cross-sections
(upper left in the yellow box) for each designated arterial segment in the location indicated by the dashed lines. Both scans provide exquisite vessel wall
depiction for the five designated arterial segments: the distal basilar artery, distal vertebral artery (VA (V4)), the distal internal carotid artery (ICA)
supraclinoid segment (C4), the middle cerebral artery (MCA) M1 segment right after the trifurcation, and the anterior cerebral artery (ACA) A1 segments
Fig. 3 Two representative clinical cases imaged with 3D intracranial vessel wall (IVW) CMR. Contrast-enhanced MRA demonstrates a severe sten-
osis at the left middle cerebral artery (MCA) M1 segment (arrow in a) in a 42-year-old male patient and a moderate stenosis at the right vertebral artery
(VA) (arrow in f) in a 48-year-old female patient. Reconstructed long-axis images from 3D whole-brain IVW scan and rescan reveal wall thickening at
both stenoses (arrows in b and d, g and i). Reconstructed short-axis (cross-section) images for the MCA plaque (c and e) and VA plaque (h and j) demon-
strate the eccentric wall thickening. Note that the delineation quality of these plaques from scan and rescan are visually comparable
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the two age groups. However, normalized wall index
and mean and maximum wall thickness were signifi-
cantly larger in the age group of ≥50 years (P ≤ 0.05).
Inter-method agreement
Figure 6 shows representative 3D IVW images and re-
formatted vessel wall cross-sections as well as slice thick-
ness- and location-matched 2D TSE images for three
arterial segments. The two acquisition methods provided
visually comparable vessel wall delineation. When all three
segments were evaluated together, all paired morphologic
measurements exhibited an excellent agreement as indicated
by an ICC with 95% CI of 0.98 (0.95–0.99), 0.96 (0.84–
0.98), 0.96 (0.92–0.97), 0.92 (0.82–0.96), and 0.88 (0.
32–0.96) for lumen volume, wall volume, normalized
wall index, mean wall thickness, and maximum wall
thickness, respectively. Segment-based morphologic
measurements and corresponding ICC values for 3D
and 2D IVW CMR are summarized in Additional file 1:
Table S2. The differences between 3D and 2D IVW
CMR and the mean values with limits of agreement for all
segments are illustrated in Bland-Altman plots (Fig. 7).
The mean differences between 3D and 2D IVW CMR
were 2.4 mm3 for lumen volume, 3.0 mm3 for vessel wall
volume, 0.002 for normalized wall index, 0.02 mm for
mean wall thickness, and 0.04 mm for maximum wall
thickness. Bland-Altman analysis demonstrated good
agreement with small bias between the two techniques.
Sample size
Table 4 shows sample size required to compare placebo
and treatment group for all measures means considering
MCA segment with 80% of power at 5% significance level
using a t-test for two independent samples with equal vari-
ance. The sample sizes required for the measures in other
segments are also presented in Additional file 1: Table S3.
Normalized wall index requires the smallest sample size
while lumen volume requires the highest sample size to
compare two groups. The large-sized segments (ICA, VA,
Table 1 Vessel wall and lumen measurements averaged over all assessed segments and corresponding ICC values of inter-scan,
intra-observer, and inter-observer reproducibilities of 3D intracranial vessel wall MR in healthy subjects
inter-scan (n = 160) Intra-observer (n = 160) Inter-observer (n = 160)
1st scan, 1st observer,
1st measurement
(mean ± SD)
2nd scan,
1st observer
(mean ± SD)
ICC
(95% CI)
1st scan, 1st observer,
2nd measurement
(mean ± SD)
ICC
(95% CI)
1st scan, 2nd
observer
(mean ± SD)
ICC
(95% CI)
Lumen volume (mm3) 42.0 ± 16.4 42.9 ± 16.8 0.99
(0.98–0.99)
43.3 ± 16.6 0.99
(0.98–0.99)
40.4 ± 17.4 0.98
(0.97–0.99)
Wall volume (mm3) 49.7 ± 15.8 49.5 ± 16.6 0.98
(0.98–0.99)
50.1 ± 15.4 0.99
(0.98–0.99)
45.7 ± 17.2 0.93
(0.80–0.96)
Normalized wall index 0.55 ± 0.04 0.54 ± 0.05 0.87
(0.80–0.91)
0.54 ± 0.04 0.93
(0.89–0.95)
0.53 ± 0.06 0.76
(0.63–0.83)
Mean wall thickness
(mm)
0.71 ± 0.11 0.70 ± 0.13 0.95
(0.93–0.96)
0.71 ± 0.11 0.96
(0.95–0.97)
0.67 ± 0.14 0.83
(0.67–0.89)
Maximum wall
thickness (mm)
0.86 ± 0.12 0.85 ± 0.15 0.93
(0.90–0.95)
0.86 ± 0.13 0.95
(0.93–0.96)
0.85 ± 0.18 0.84
(0.78–0.88)
SD standard deviation, ICC intra-class correlation coefficient, CI confidence intervals
Table 2 Vessel wall and lumen measurements at the most stenotic plaques and corresponding ICC values of inter-scan, intra-observer,
and inter-observer reproducibilities of 3D intracranial vessel wall MR in patients
Inter-scan (n = 9) Intra-observer (n = 9) Inter-observer (n = 9)
1st scan, 1st observer,
1st measurement
(mean ± SD)
2nd scan,
1st observer
(mean ± SD)
ICC
(95% CI)
1st scan, 1st observer,
2nd measurement
(mean ± SD)
ICC
(95% CI)
1st scan,
2nd observer
(mean ± SD)
ICC
(95% CI)
Lumen volume (mm3) 25.1 ± 18.2 26.57 ± 21.33 0.99
(0.94–0.99)
25.7 ± 17.6 0.99
(0.99–0.99)
23.7 ± 18.0 0.99
(0.96–0.99)
Wall volume (mm3) 54.2 ± 32.6 55.36 ± 31.82 0.99
(0.97–0.99)
54.5 ± 29.4 0.99
(0.96–0.99)
50.2± 26.3 0.98
(0.90–0.99)
Normalized wall index 0.69 ± 0.08 0.69 ± 0.10 0.93
(0.66–0.98)
0.69 ± 0.09 0.98
(0.89–0.99)
0.69 ± 0.10 0.92
(0.65–0.98)
Mean wall thickness (mm) 0.90 ± 0.29 0.92 ± 0.28 0.97
(0.89–0.99)
0.91 ± 0.25 0.97
(0.89–0.99)
0.88 ± 0.25 0.97
(0.86–0.99)
Maximum wall thickness (mm) 1.35 ± 0.37 1.39 ± 0.31 0.91
(0.59–0.98)
1.44 ± 0.37 0.94
(0.76–0.99)
1.25 ± 0.29 0.87
(0.49–0.97)
SD standard deviation, ICC intra-class correlation coefficient, CI confidence intervals
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and BA) requires the smaller sample size than small-sized
segments (MCA and ACA).
Discussion
A non-invasive imaging method for reliably quantifying
longitudinal morphologic changes in ICAD is potentially
useful in medical management or drug development.
High-resolution black-blood 2D CMR, traditionally used
for ICAD imaging, has been shown to be a morphology-
probing tool with good intra- and inter-observer agree-
ment [27] as well as low scan-rescan variability [28]. With
aforementioned technical advantages that are more rele-
vant to vessel wall morphologic assessments, 3D IVW
CMR has increasingly been advocated as a non-invasive
imaging modality for ICAD research [9–15]. However, its
applicability in longitudinal imaging evaluations has yet to
Fig. 4 Bland-Altman plots for lumen volume (a inter-scan, b intra-observer, c inter-observer), normalized wall index (d inter-scan, e intra-observer, f
inter-observer), and mean wall thickness (g inter-scan, h intra-observer, i inter-observer). The solid lines represent the mean difference, and the dashed
lines indicate the 95% limits of agreement. SD = standard deviation
Fig. 5 The comparison of ICCs (95% CI) for all vessel wall and lumen measurements among patients and different age groups of healthy subjects.
ICC = intra-class correlation coefficient; CI = confidence interval
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be established. Thus, the present study sought to conduct
a comprehensive investigation on its reliability in the
quantification of intracranial vessel dimensions.
Scan-rescan reproducibility is a paramount require-
ment for an imaging modality to be used for serial ex-
aminations. Our results showed excellent scan-rescan
reproducibility in measuring the dimensions of major
intracranial arterial segments for healthy subjects and
plaques for patients with all ICCs ≥0.87 and 0.91, re-
spectively. A previous study on using 2D IVW CMR for
evaluating MCA lumen and plaque area/volume showed
better ICCs (0.97 or higher) [28]. This is likely because
the 3D technique is more susceptible to any errors
caused by, for example, image registration, reformation,
and vessel wall contouring, particularly in healthy sub-
jects where the vessel wall is thinner. A more recent
Table 3 The comparison for the vessel wall and lumen measurements averaged over two observers between different
age subgroups. Data are presented as means ± standard deviations
Age group Lumen volume (mm3) Wall volume (mm3) Normalized wall indexa Mean wall thickness (mm)a Maximum wall thickness (mm)a
≥50 years 41.2 ± 16.7 50.5 ± 16.0 0.55 ± 0.06 0.69 ± 0.14 0.88 ± 0.18
< 50 years 47.7 ± 16.1 48.9 ± 15.5 0.51 ± 0.04 0.63 ± 0.14 0.80 ± 0.17
P value 0.23 0.61 < 0.001 0.05 0.03
adenotes statistical significance
Fig. 6 Representative 3D intracranial vessel wall CMR images (left and middle columns: two different long axis views; right column: reformatted
cross-sections in the location indicated by the dashed lines in long axis views) and corresponding 2D intracranial vessel wall CMR images in a 31-year-
old male volunteer. 3D intracranial vessel wall CMR and 2D TSE provide comparable vessel wall delineation for the three arterial segments: distal basilar
artery, distal internal carotid artery (ICA) supraclinoid segment (C4), and the proximal M1 segment of middle cerebral artery (MCA). All cross-sectional
images reformatted from 3D IVW MR are of 2-mm thickness, matched with that on 2D TSE images
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population-based study has reported considerably lower
reproducibility in wall volume, normalized wall index,
and mean wall thickness for a 3D IVW CMR sequence
[25]. One of major possible reasons for the better per-
formance of the whole-brain IVW CMR sequence in our
study is that two repeat scans were in the same imaging
session in healthy volunteers or days apart in patients..
Clearly this same-session investigation strategy for
healthy subjects only reveals the scan-rescan repeatabil-
ity instead of the true longitudinal repeatability of a
technique, but has commonly been used in many previ-
ous studies [26, 28, 29]. Nevertheless, our findings sug-
gest the possibility for reliable serial examination of
IVW using the 3D whole-brain IVW CMR technique as
previous carotid studies did [26, 29, 30].
Our study also revealed excellent intra- and inter-
observer reproducibility in quantifying intracranial vessel
dimensions. In general, all ICCs were better than those
reported by the recent population-based study whereby
a slab-selective 3D IVW CMR sequence was used [25].
Our evaluations were focused on a recently developed
whole-brain vessel wall CMR imaging method because
of its several technical advantages over other existing
slab-selective 3D IVW imaging techniques [18]. A note-
worthy feature is its more superior delineation of the
outer vessel wall boundary due to an improved signal
suppression in surrounding CSF [18]. Additionally, rela-
tively short echo time due to the use of a non-selective
excitation radio-frequency pulse may contribute to bet-
ter overall image SNR. Hence, quantification of vessel
area, wall area, and wall thickness would potentially be
more accurate.
As part of reliability analysis, the present study investi-
gated the inter-method agreement between 3D IVW
CMR and conventionally used 2D TSE. The lumen and
vessel wall volume and normalized wall index measured
from 3D IVW CMR showed excellent accordance with
those measured from conventional 2D TSE (ICC > 0.96)
despite potential registration errors. This corroborates
the findings reported in the previous study [9]. The ICCs
of mean and maximum wall thickness, particularly the
latter, were slightly lower, which could be explained by
the fact that these measurements are more prone to
Table 4 Sample Sizes per Group for differences of 5%, 10%,
15%, and 20% from placebo group mean estimated in the
middle cerebral artery segment based on the inter-scan analysis
Placebo group
(mean ± SD)
Sample size
5% 10% 15% 20%
Lumen volume (mm3) 38.9 ± 8.9 329 83 38 22
Wall volume (mm3) 41.1 ± 7.6 215 55 25 15
Normalized wall index 0.52 ± 0.05 60 16 8 5
Mean wall thickness (mm) 0.63 ± 0.08 103 27 13 8
Maximum wall thickness (mm) 0.77 ± 0.1 107 28 13 8
SD standard deviation
Fig. 7 Bland-Altman plots of the difference versus mean for the 3D and 2D intracranial vessel wall CMR paired intracranial vessel wall and lumen
measurements show good agreement with a small bias of 2.4 mm3, 3.0 mm3, 0.002, 0.02 mm, and 0.04 mm for lumen volume (a), vessel wall
volume (b), normalized wall index (c), mean wall thickness (d) and maximum wall thickness (e), respectively. The solid lines represent the mean
difference, and the dashed lines indicate the 95% limits of agreement. SD = standard deviation
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outliers [26]. Nevertheless, they generally showed excel-
lent agreement between the two techniques. While the
accuracy of the 3D technique is questionable due to the
lack of histology validation, our finding suggests that this
technique is at least comparable to the 2D technique
and can be utilized as a more time-efficient ICAD im-
aging method. Given the much higher and isotropic
spatial resolution and flexibility in image reformation
with 3D imaging, the geometry of small lesions from the
tortuous intracranial arteries would, in theory, be quanti-
fied more accurately.
In general, relatively large-sized segments exhibited
higher reproducibility and smaller sample size required
than small-sized segments, and the age group of
≥50 years demonstrated equal or higher reproducibility
than the younger group. Additionally, the patient group
demonstrated an even better reproducibility than the
age group of ≥50. This is perhaps explained by the
thicker vessel wall in large-sized segments and in older
subjects or patients that is favorable for morphologic
quantification. Our results did show that normalized
wall index and mean and maximum wall thickness were
significantly larger in the age group of ≥50 years versus
the younger group and in the patient group versus the
healthy group. The limit in spatial resolution and associ-
ated errors in image registration and contouring are
thought of as major factors influencing the measurement
consistency. It is noteworthy that in clinical patients
who have ICAD lesions or dramatically thickened vessel
wall, such an effect might be alleviated. Additionally, 0.
5 mm spatial resolution provided by the whole-brain
IVW CMR technique is currently the best choice given
the trade-off between imaging time and diagnostic qual-
ity as recommended [31].
With such high reproducibility of vessel dimension
measurements, whole-brain IVW CMR imaging can po-
tentially be translated into research and clinical applica-
tions for monitoring disease progression and therapeutic
response. More importantly, higher inter-scan reprodu-
cibility promises fewer participants for therapeutic trial
enrollment and reduced cost. Sample sizes for MCA seg-
ment presented are higher than Zhang et al. [28] be-
cause they based their calculations on the standard
deviation between scans while we used standard devia-
tions resulting from the total variance decreased by the
variance between scans as Mihai et al. [32].
There are limitations with this work. First, we focused
reliability analyses on healthy subjects and only 9 pa-
tients were included. Despite relatively large vessel wall
dimension in ICAD patients which favors morphologic
measurement, reproducibility could be compromised by,
for example, reduced image quality due to motion. Re-
producibility studies based on healthy subjects have
commonly been investigated in the field of vessel wall
CMR imaging [9, 26, 29, 33]. The results from this type
of study may provide indication of the technical per-
formance in general populations as well as insights into
planning future studies on clinical patients. Second, the
3D technique is still susceptible to motion artifacts
which occurred in 6 out of 34 healthy subjects and in 1
out of 10 patients. Four of the 6 healthy subjects were
still eligible for analysis as reacquisition was of accept-
able image quality. Hence, our conclusion holds valid
when only considering cases with acceptable diagnostic
quality. Further improvement in motion resistance is
clearly necessary to foster the technique’s clinical reli-
ability. Third, the scan and rescan were performed on
the same CMR scanner with the same CMR technolo-
gist. Thus, we could not estimate any variation caused
by imaging scanners or between MR technologists.
Conclusion
In conclusion, whole-brain 3D IVW CMR is a reliable
CMR imaging method for the quantification of intracra-
nial vessel dimensions and could potentially be useful
for monitoring plaque progression and regression.
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